Mahadevan D - Search Results

1

Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma.

Badruddoja MA, Pazzi M, Sanan A, Schroeder K, Kuzma K, Norton T, Scully T, Mahadevan D, Ahmadi MM. Badruddoja MA, et al. Among authors: mahadevan d. Cancer Chemother Pharmacol. 2018 Jan;81(1):223. doi: 10.1007/s00280-017-3448-9. Cancer Chemother Pharmacol. 2018. PMID: 29034406 No abstract available.

2

Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastoma.

Badruddoja MA, Pazzi M, Sanan A, Schroeder K, Kuzma K, Norton T, Scully T, Mahadevan D, Ahmadi MM. Badruddoja MA, et al. Among authors: mahadevan d. Cancer Chemother Pharmacol. 2017 Oct;80(4):715-721. doi: 10.1007/s00280-017-3405-7. Epub 2017 Aug 14. Cancer Chemother Pharmacol. 2017. PMID: 28808777 Clinical Trial.

3

Expression Levels of RAD51 Inversely Correlate with Survival of Glioblastoma Patients.

Morrison C, Weterings E, Mahadevan D, Sanan A, Weinand M, Stea B. Morrison C, et al. Among authors: mahadevan d. Cancers (Basel). 2021 Oct 26;13(21):5358. doi: 10.3390/cancers13215358. Cancers (Basel). 2021. PMID: 34771522 Free PMC article.

4

Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients.

Mahadevan D, Mita M, Richards D, McClay E, Heist RS, Kumar A, Sundararajan S, Naing A. Mahadevan D, et al. Cancer Chemother Pharmacol. 2017 Apr;79(4):681-688. doi: 10.1007/s00280-017-3258-0. Epub 2017 Mar 13. Cancer Chemother Pharmacol. 2017. PMID: 28289865 Clinical Trial.

5

Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies.

Mahadevan D, Sutton GR, Arteta-Bulos R, Bowden CJ, Miller PJ, Swart RE, Walker MS, Haluska P, Munster PN, Marshall J, Hamid O, Kurzrock R. Mahadevan D, et al. Cancer Chemother Pharmacol. 2014 Mar;73(3):467-73. doi: 10.1007/s00280-013-2372-x. Epub 2014 Jan 4. Cancer Chemother Pharmacol. 2014. PMID: 24390424 Clinical Trial.

6

Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.

Mahadevan D, Unger JM, Spier CM, Persky DO, Young F, LeBlanc M, Fisher RI, Miller TP. Mahadevan D, et al. Cancer. 2013 Jan 15;119(2):371-9. doi: 10.1002/cncr.27733. Epub 2012 Jul 25. Cancer. 2013. PMID: 22833464 Free PMC article. Clinical Trial.

7

An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.

De P, Dey N, Terakedis B, Bergsagel PL, Li ZH, Mahadevan D, Garlich JR, Trudel S, Makale MT, Durden DL. De P, et al. Among authors: mahadevan d. Cancer Chemother Pharmacol. 2013 Apr;71(4):867-81. doi: 10.1007/s00280-013-2078-0. Epub 2013 Jan 25. Cancer Chemother Pharmacol. 2013. PMID: 23355037 Free PMC article. Clinical Trial.

8

Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer.

Riley CJ, Engelhardt KP, Saldanha JW, Qi W, Cooke LS, Zhu Y, Narayan ST, Shakalya K, Croce KD, Georgiev IG, Nagle RB, Garewal H, Von Hoff DD, Mahadevan D. Riley CJ, et al. Among authors: mahadevan d. Cancer Res. 2009 Mar 1;69(5):1933-40. doi: 10.1158/0008-5472.CAN-08-2707. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244123 Free PMC article.

9

Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma.

Qi W, Cooke LS, Liu X, Rimsza L, Roe DJ, Manziolli A, Persky DO, Miller TP, Mahadevan D. Qi W, et al. Among authors: mahadevan d. Biochem Pharmacol. 2011 Apr 1;81(7):881-90. doi: 10.1016/j.bcp.2011.01.017. Epub 2011 Feb 1. Biochem Pharmacol. 2011. PMID: 21291867 Free PMC article.

10

Phase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies.

Mahadevan D, Dreisbach L, Kristedja T, Williams D, Obregon Y, Kurtin S, Von Hoff DD. Mahadevan D, et al. Am J Clin Oncol. 2009 Dec;32(6):607-11. doi: 10.1097/COC.0b013e31819cc9ed. Am J Clin Oncol. 2009. PMID: 19593083 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters